Bridger Management »

Alnylam Pharmaceuticals shares owned by Bridger Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Bridger Management from 13F filings

Historical chart of Bridger Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Bridger Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Bridger Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $33M 1.4M 24.37
2012-09-30 $30M 1.6M 18.79

More positions owned by Bridger Management

Eli Lilly & Co. (LLY)
Uber Technologies (UBER)
Vertex Pharmaceuticals Incorporated (VRTX)
Morgan Stanley Com New (MS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Pfizer (PFE)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alnylam Pharmaceuticals (ALNY)
Bath &#38 Body Works In (BBWI)
Bausch Plus Lomb Corp Common Shares (BLCO)
Melco Resorts And Entmnt Adr (MLCO)
Caesars Entertainment (CZR)
Xenon Pharmaceuticals (XENE)
Geron Corporation (GERN)
Springworks Therapeutics (SWTX)

View all positions for Bridger Management

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
Vanguard Group
BlackRock
BlackRock
Capital Research Global Investors
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies
Groupama Asset Managment

View all funds holding Alnylam Pharmaceuticals